Program

 

22 November

08:30Registration and Walk-In Coffee
 
09:00Workshop Opening
 Session 1: Natural History and Epidemiology

 
09:10

Colombo, Massimo 2011

Natural History of NASH
Massimo Colombo, MD
Humanitas Research Hospital, Rozzano, Italy

 
09:40

Jeffrey Lazarus, PhD, MIH, MAIsglobal, Hospital Clínic, Univ of Barcelona, Spain

NASH Epidemiology and policy
Jeffrey Lazarus, PhD, MIH, MA
Isglobal, Hospital Clínic, Univ of Barcelona, Spain

10:10

Pryke, Rachel 2019 120x160

NASH Diagnosis and Management in General Practice
Rachel Pryke, MBBS MRCGP FRCP
Winyates Health Centre, United Kingdom

10:40Discussion
11:00Coffee Break
 Session 2: Clinical Management of NASH - Diabetes and Obesity

11:30

Oben, Jude 2019

Practical Guidance Obesity Management - Introductory Talk 
Jude Oben, MD
University College London

12:00

Practical Guidance Diabetes management - Introductory Talk
(speaker to be confirmed)

12:30

Discussion

12:35Lunch and Poster Viewing
 Session 3: Clinical Management of NASH - Special Populations

13:45

Management of Lean NASH
Ramy Younes, MD
University of Turin, Turin, Italy

14:15

Baker, Alastair 2019

Practical guidance on pediatrics NAFLD  (incl. clinical cases) 
Alastair Baker, MB, ChB, FRCP, FRCPCH, MBA
King's College Hospital NHS Foundation Trust, United Kingdom

14:45

NASH in HIV
Berend van Welzen, MD
UMC Utrecht, the Netherlands

15:15Discussion
15:30 Coffee Break
 Session 4: NASH Management

16:00

Manuel Romero-Gomez, MDUniversity of Seville, Spain

New Biomarkers in NAFLD
Manuel Romero-Gomez, MD
University of Seville, Spain

16:30

Zelber-Sagi Shira, 2018 120x160

How to Implement a Healthy Lifestyle in NAFLD/NASH Patients
Shira Zelber-Sagi, PhD
Tel Aviv Sourasky Medical Center, Israel

17:00Roundtable Discussion: The Interface of Primary and Secondary Care
Moderator: Emmanouil Tsochatzis, MD, PhD, Royal Free Hospital, United Kingdom
17:30Open Poster Session and Welcome Reception
19:30Workshop Dinner

23 November

 Session 5: NASH and Comorbidities

09:00

Reeves, Helen 2019 120x160

NASH/NAFLD as Cause for HCC
Helen Reeves, MD, PhD
Newcastle Universtity, United Kingdom

09:20

Andrade, Raul 2019 120x160

Drug-Induced Liver Injury and NASH
Raúl Andrade, ND, PhD
University Hospital Virgen de la Victoria, Malaga, Spain

09:40

Schattenberg,Joern 2018

Cardiovascular Risk in NAFLD
Jörn M. Schattenberg, MD
Johannes Gutenberg-Universität Mainz, Germany

10:00

Arias-Loste, Maria Teresa 2019 120x160

NASH and Immune-Mediated Diseases
Maria Teresa Arias-Loste, MD
Hospital Universitario Marques de Valdecilla, Santander, Spain

10:20Discussion
10:30Coffee Break
 Session 6: Future Treatment and Management Options

11:00

Ratziu, Vlad - 2019 120x160

Invited Lecturer
Vlad Ratziu, MD, PhD 
Pierre and Marie Curie University, Paris, France

11:30

Gender neutral avatar 120x160

Patient Perspective
(speaker to be confirmed)

11:45Round Table Discussion: Current guidelines -  still relevant or in need for review?
(moderator to be confirmed)
12:15Closing Remarks
12:30Closure of the Workshop